Apogee Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
APGE
CUSIP
03770N101
Type
Equity
Class
COM
Num filings
149
Total reported value, excl. options
$3.29 B
Manager Report Date Value ($000) Shares Option Type